PE0139 Injection

DRUG2 trials

Sponsors

PhaseBio Pharmaceuticals Inc.

Conditions

Type 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

Phase 1

Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

CompletedNCT01835730

PhaseBio Pharmaceuticals Inc.Type 2 Diabetes Mellitus (T2DM)

Start: 2013-04-30End: 2014-05-31Updated: 2014-10-15

Phase 2

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

CompletedNCT02581657

PhaseBio Pharmaceuticals Inc.Type 2 Diabetes Mellitus

Start: 2015-10-31End: 2016-11-30Updated: 2018-04-10